Μαρία Γαζούλη
2019EOMIFNEp3

Type I and II interferon signatures can predict the response to anti-TNF agents in inflammatory bowel disease patients: involvement of the microbiota, Inflamm Bowel Dis 2020

Καλλιόπη Φωτεινογιαννοπούλου, Ιωάννης Κουτρουμπάκης
2019EOMIFNEmp1

The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study, BMC Gastroenterol 2021

Μαρία Γαζούλη
2017EOMIFNEp5

The interplay between mucosal microbiota composition and host gene-expression is linked with infliximab response in inflammatory bowel diseases, Microorganisms 2020

Χαρίλαος Τριανταφύλλου, Ιωάννης Παπακωνσταντίνου
2017EOMIFNEp1

Effects of anti-inflammatory treatment and surgical intervention on endothelial glycocalyx, peripheral and coronary microcirculatory function and myocardial deformation in inflammatory bowel disease patients: A two-arms two-stage clinical trial, Diagnostics (Basel) 2021

Αντώνιος Γκλαβάς, Ιωάννης Παπακωνσταντίνου
2016EOMIFNEp3

Specific neuropeptide expression in Crohn's disease ileocolonic resection specimens is not associated with plexitis at the ileal margin or postoperative recurrence, J Gastrointest Surg 2022

Χρήστος Πόντας, Γεράσιμος Μάντζαρης
2016EOMIFNEp2

Efficacy of switching from infliximab to golimumab in patients with ulcerative colitis in deep remission, Acta Gastroenterol Belg 2021